Completed PHASE3 INTERVENTIONAL 2-arm NCT01375348

Relationship Between Cognitive Function and Pain

Cognitive Function in Healthy Volunteers Exposed to Acute Pain Before and After Administration of Remifentanil

Sponsor: Mech-Sense

Interventions Ultiva (remifentanil) or placebo

Updated 5 times since 2017 Last updated: Feb 13, 2012 Started: Jun 30, 2011 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cognitive Ability, General, this trial is completed. The trial is conducted by Mech-Sense and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mech-Sense
University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aalborg, Denmark